Skip to content

NYSE · CIK 0001628908

EVH Evolent Health, Inc.

Insider trading from SEC Form 4. Last filing Mar 10, 2025.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
13
with a Form 4 at this company

Signals

Open-market buys and sells at Evolent Health, Inc., scored.

ScoreSideInsiderValueSharesHoldings changePrice contextFiled
33Weakbuy 9Craig A. Barbarosh
director
$18k2,000+7%-
61Notablebuy 9Seth Blackley
Chief Executive Officer
$498k55,225+8%-
46Moderatebuy 9Kim Keck
director
$99k10,540+36%-
47Moderatebuy 9Russell Monroe Glass
director
$50k5,400+61%-
56Moderatebuy 9Brendan B Springstubb
director
$139k15,000+127%-
50Moderatebuy 9Peter J Grua
director
$99k11,040+143%-
51Moderatebuy 9Richard M Jelinek
director
$274k30,000--
45Moderatebuy 9Daniel Joseph McCarthy
PRESIDENT
$99k11,040+3%-
35Weakbuy 9Diane Holder
director
$26k2,735+4%-
46Moderatebuy 9Brendan B Springstubb
director
$44k5,000+73%-

Transactions

The last 36 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Mar 7, 2025Brendan B Springstubb
director
POpen-market purchase
Class A Common Stock
+15,000$9.27$139k26,842Mar 10, 2025
Mar 7, 2025Kim Keck
director
POpen-market purchase
Class A Common Stock
+10,540$9.44$99k39,522Mar 10, 2025
Mar 6, 2025Diane Holder
director
POpen-market purchase
Class A Common Stock
+2,735$9.33$26k70,584Mar 10, 2025
Mar 6, 2025Daniel Joseph McCarthy
PRESIDENT
POpen-market purchase
Class A Common Stock
+11,040$9.01$99k389,004Mar 10, 2025
Mar 6, 2025Peter J Grua
director
POpen-market purchase
Class A Common Stock
+11,040$9.01$99k18,749Mar 10, 2025
Mar 6, 2025Russell Monroe Glass
director
POpen-market purchase
Class A Common Stock
+5,400$9.27$50k14,272Mar 10, 2025
Mar 6, 2025Seth Blackley
Chief Executive Officer
POpen-market purchase
Class A Common Stock
+55,225$9.01$498k762,217Mar 10, 2025
Mar 6, 2025Craig A. Barbarosh
director
POpen-market purchase
Class A Common Stock
+2,000$8.81$18k31,956Mar 10, 2025
Mar 7, 2025Richard M Jelinek
director
POpen-market purchase
Class A Common Stockindirect: By the Richard M Jelinek Revocable Trust
+15,000$9.16$137k15,000Mar 10, 2025
Mar 7, 2025Richard M Jelinek
director
POpen-market purchase
Class A Common Stockindirect: By the Richard M Jelinek GST
+15,000$9.09$136k15,000Mar 10, 2025
Mar 3, 2025Brendan B Springstubb
director
AGrant or award
Class A Common Stock
+6,842$0.00$06,842Mar 5, 2025
Mar 4, 2025Brendan B Springstubb
director
POpen-market purchase
Class A Common Stock
+5,000$8.75$44k11,842Mar 5, 2025
Mar 1, 2025Emily Ann Rafferty
Chief Operating Officer
FTax withholding
Class A Common Stock
-9,274$8.99$83k54,134Mar 4, 2025
Mar 1, 2025Daniel Joseph McCarthy
PRESIDENT
FTax withholding
Class A Common Stock
-15,143$8.99$136k173,197Mar 4, 2025
Mar 1, 2025Aammaad Shams
Chief Accounting Officer
FTax withholding
Class A Common Stock
-5,546$8.99$50k46,833Mar 4, 2025
Mar 1, 2025Jonathan Weinberg
General Counsel
FTax withholding
Class A Common Stock
-8,808$8.99$79k158,219Mar 4, 2025
Mar 1, 2025John Paul Johnson
Chief Financial Officer
FTax withholding
Class A Common Stock
-9,246$8.99$83k161,961Mar 4, 2025
Mar 1, 2025Seth Blackley
Chief Executive Officer
FTax withholding
Class A Common Stock
-28,535$8.99$257k383,389Mar 4, 2025
Mar 3, 2025Seth Blackley
Chief Executive Officer
AGrant or award
Class A Common Stock
+235,025$0.00$0618,414Mar 4, 2025
Mar 3, 2025Aammaad Shams
Chief Accounting Officer
AGrant or award
Class A Common Stock
+25,151$0.00$071,984Mar 4, 2025
Mar 3, 2025John Paul Johnson
Chief Financial Officer
AGrant or award
Class A Common Stock
+89,113$0.00$0251,074Mar 4, 2025
Mar 3, 2025Daniel Joseph McCarthy
PRESIDENT
AGrant or award
Class A Common Stock
+156,683$0.00$0329,880Mar 4, 2025
Mar 3, 2025Jonathan Weinberg
General Counsel
AGrant or award
Class A Common Stock
+65,470$0.00$0223,689Mar 4, 2025
Mar 3, 2025Emily Ann Rafferty
Chief Operating Officer
AGrant or award
Class A Common Stock
+72,937$0.00$0127,071Mar 4, 2025
Mar 3, 2025Emily Ann Rafferty
Chief Operating Officer
AGrant or award
Class A Common Stock
+5,490$0.00$0132,561Mar 4, 2025
Mar 3, 2025Seth Blackley
Chief Executive Officer
AGrant or award
Class A Common Stock
+161,346$0.00$0779,760Mar 4, 2025
Mar 3, 2025John Paul Johnson
Chief Financial Officer
AGrant or award
Class A Common Stock
+59,582$0.00$0310,656Mar 4, 2025
Mar 3, 2025Jonathan Weinberg
General Counsel
AGrant or award
Class A Common Stock
+10,640$0.00$0234,329Mar 4, 2025
Mar 3, 2025Daniel Joseph McCarthy
PRESIDENT
AGrant or award
Class A Common Stock
+87,585$0.00$0417,465Mar 4, 2025
Mar 3, 2025Aammaad Shams
Chief Accounting Officer
AGrant or award
Class A Common Stock
+6,650$0.00$078,634Mar 4, 2025
Mar 3, 2025Emily Ann Rafferty
Chief Operating Officer
FTax withholding
Class A Common Stock
-2,433$8.77$21k130,128Mar 4, 2025
Mar 3, 2025Daniel Joseph McCarthy
PRESIDENT
FTax withholding
Class A Common Stock
-39,501$8.77$346k377,964Mar 4, 2025
Mar 3, 2025John Paul Johnson
Chief Financial Officer
FTax withholding
Class A Common Stock
-26,872$8.77$236k283,784Mar 4, 2025
Mar 3, 2025Aammaad Shams
Chief Accounting Officer
FTax withholding
Class A Common Stock
-3,168$8.77$28k75,466Mar 4, 2025
Mar 3, 2025Seth Blackley
Chief Executive Officer
FTax withholding
Class A Common Stock
-72,768$8.77$638k706,992Mar 4, 2025
Mar 3, 2025Jonathan Weinberg
General Counsel
FTax withholding
Class A Common Stock
-3,544$8.77$31k230,785Mar 4, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

EVH insider trading: Evolent Health, Inc. | InsiderTell